Richard Edwin Martin
Physician at Aberdeen Ave, Englewood, CO

License number
Colorado 26303
Issued Date
Oct 11, 1984
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
10308 E Aberdeen Ave, Englewood, CO 80111

Professional information

See more information about Richard Edwin Martin at trustoria.com
Richard Martin Photo 1
Diagnosing Asthma Patients Predisposed To Adverse Beta-Agonist Reactions

Diagnosing Asthma Patients Predisposed To Adverse Beta-Agonist Reactions

US Patent:
2002011, Aug 29, 2002
Filed:
Nov 21, 2001
Appl. No.:
09/990596
Inventors:
Jeffrey Drazen - Winchester MA, US
Vern Chinchilli - Elizabethtown PA, US
Richard Martin - Englewood CO, US
Robert Lemanske - Madison OH, US
Jean Ford - Newark NJ, US
James Fish - Gladwyne PA, US
Homer Boushey - San Francisco CA, US
International Classification:
C12Q001/68, C12P019/34
US Classification:
435/006000, 435/091200
Abstract:
The present invention provides a novel method for identifying individuals who are likely to have negative responses to regular administration of -agonists. The invention also provides kits useful for this purpose.


Richard Martin Photo 2
Diagnosing Asthma Patients Predisposed To Adverse .Beta.-Agonist Reactions

Diagnosing Asthma Patients Predisposed To Adverse .Beta.-Agonist Reactions

US Patent:
6156503, Dec 5, 2000
Filed:
Mar 3, 1997
Appl. No.:
8/811441
Inventors:
Jeffrey M. Drazen - Winchester MA
Vern Chinchilli - Elizabethtown PA
Richard Martin - Englewood CO
Robert Lemanske - Madison MS
Jean G. Ford - Newark NJ
James E. Fish - Gladwyne PA
Homer Boushey - San Francisco CA
Assignee:
The Regents of the University of California - Oakland CA
The Trustees of Columbia University in the City of New York - New York NY
The Penn State Research Foundation - University Park PA
National Jewish Medical and Research Center - Denver CO
Wisconsin Alumni Research Center - Madison WI
Thomas Jefferson University - Philadelphia PA
Brigham and Women's Hospital - Boston MA
International Classification:
C12Q 168, C07H 2104
US Classification:
435 6
Abstract:
The present invention provides a novel method for identifying individuals who are likely to have negative responses to regular administration of. beta. -agonists. The invention also provides kits useful for this purpose.